Northwest & Ethical Investments L.P. Buys 183 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Northwest & Ethical Investments L.P. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 15,924 shares of the medical equipment provider’s stock after purchasing an additional 183 shares during the quarter. Northwest & Ethical Investments L.P.’s holdings in Intuitive Surgical were worth $8,311,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical in the fourth quarter worth $82,517,000. Sycomore Asset Management raised its holdings in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC raised its holdings in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its holdings in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $491.81 on Friday. The stock has a market capitalization of $175.17 billion, a price-to-earnings ratio of 76.73, a PEG ratio of 5.85 and a beta of 1.43. The stock’s 50-day simple moving average is $563.34 and its two-hundred day simple moving average is $531.34. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ISRG. Stifel Nicolaus increased their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Barclays increased their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Citigroup increased their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Leerink Partners increased their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.